NCT07353905 Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
| NCT ID | NCT07353905 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | Peripheral Arterial Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2025-12-12 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2025-12-12 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Symptomatic LE PAD - Rutherford Class 2-5 * Angiographic evidence of \>50% stenosis * Undergoing LE peripheral artery intervention * Target lesion is iliac, femoropopliteal, profunda or supramalleolar below-the-knee arteries (target lesions extending into the abdominal aorta and inframalleolar BTK may be included). Exclusion Criteria: * Prior intervention at the target lesion within 6 months * Target lesion is abdominal aorta or inframalleolar BTK arteries
Contact & Investigator
Subhash Banerjee, MD
PRINCIPAL INVESTIGATOR
Baylor Scott & White Research Institute
Frequently Asked Questions
Who can join the NCT07353905 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peripheral Arterial Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07353905 currently recruiting?
Yes, NCT07353905 is actively recruiting participants. Contact the research team at sarah.hale@bswhealth.org for enrollment information.
Where is the NCT07353905 trial being conducted?
This trial is being conducted at Dallas, United States, Fort Worth, United States, McKinney, United States, Plano, United States and 2 additional locations.
Who is sponsoring the NCT07353905 clinical trial?
NCT07353905 is sponsored by Baylor Research Institute. The principal investigator is Subhash Banerjee, MD at Baylor Scott & White Research Institute. The trial plans to enroll 350 participants.